Jump to navigation
Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
By Eteena Tadjiogueu
A key message in our Sustainable Immunization Financing (SIF) Program work is that countries need to reduce their dependencies by appropriating their routine immunization programs.
The 9th International Rotavirus Symposium brought together 365 participants from 65 countries from August 2-3, 2010 in Johannesburg, South Africa.
By Stephanie Bricking, Albert B. Sabin Archivist, University of Cincinnati